Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo vs IR Carbidopa/Levodopa for Non-motor Symptoms in Parkinson's Disease
NCT00642356Phase 4Terminated
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Novartis. Primary endpoint: Change From Baseline on the Non-motor Score of the Quantitative Wearing-Off Questionnaire 9 Item at 8 weeks. Started Mar 2008; status: terminated.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00642356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642356.